Katarzyna Holcman
Katarzyna Holcman is an expert in Cardiology at John Paul II Hospital (Poland). As of September 2026, ScienceLeadR ranks Katarzyna Holcman in the top 1% of experts in Poland for Transthyretin amyloidosis and Proteostasis Deficiencies. Katarzyna Holcman has authored 95 publications, the most recent in 2026, and is an investigator in 2 clinical trials, 1 of them ongoing. SLR score: 352 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Medical Imaging - Internal Medicine - Nuclear Medicine
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2014 - 2026
Number : 95
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Severe tricuspid regurgitation: aetiology, patient characteristics and treatment - a multicentre, prospective registry. PMID 42462158 — registries, mortality, heart failure, hospital mortality, tricuspid valve, signs and symptoms, therapeutics, tricuspid valve insufficiency | ESC Heart Fail | 2026 | 0 |
| Enhanced cardiac sympathetic innervation predicts systolic function improvement and outcome in dilated cardiomyopathy. PMID 42267514 — cardiomyopathy, dilated, cardiovascular diseases, cardiology, cardiomyopathies | Cardiol J | 2026 | 0 |
| Genetic determinants of Staphylococcus aureus adhesion shape virulence trade-offs in bacteremia. PMID 42156734 — bacteremia, tissue adhesions, staphylococcus, fibrinogen, adhesives, staphylococcus aureus, fibronectins, virulence, infections | Nat Commun | 2026 | 0 |
| First quinquennium completed: highlights from EHJ Open 2025. PMID 42146872 | Eur Heart J Open | 2026 | 0 |
| Gated SPECT Imaging of Left Ventricular Mechanical Dyssynchrony: Predictive Value in Cardiac Resynchronization Therapy Candidates. PMID 41912136 — predictive value of tests, cardiac resynchronization therapy, tomography, emission-computed, single-photon, heart failure, systolic, echocardiography, therapeutics, electrocardiography | J Nucl Cardiol | 2026 | 0 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| New Biomarkers and Plasma Prothrombotic Potential in Cardiac Transthyretin Amyloidosis NCT06345235 — amyloid neuropathies, matrix metalloproteinase 9, tissue inhibitor of metalloproteinase-1, laboratories, blood, tissue inhibitor of metalloproteinases, galectins, heart failure, heart, galectin 3, enzyme-linked immunosorbent assay, prealbumin, biomarkers, amyloidosis, matrix metalloproteinases, amyloid, metalloproteases, tissues, hematologic tests, cardiomyopathies, plasma, amyloid neuropathies, familial, transthyretin amyloidosis | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map